Concepedia
Statistics
Publications
10
Citations
297
H-Index
Active since
1990
Affiliations
University of Kansas Medical Center(Current)
The University of Kansas Cancer Center
Princess Margaret Cancer Centre
Washington University in St. Louis
Rutgers, The State University of New Jersey
Andrea Jewell is an author at University of Kansas Medical Center specializing in medicine, oncology, and cancer therapeutics.
Top concepts
MedicineOncologyGynecologyCancer TherapyPharmacologyOvarian CancerMolecular OncologyRadiation OncologyGynecology OncologyGenetics
Publications per year
1990–2023
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Stéphanie Lheureux, Daniela Matei, Panagiotis A. Konstantinopoulos et al. · Journal for ImmunoTherapy of Cancer · 2022 · 58 citations · Full text
Differential phosphorylation of connexin46 and connexin50 by H2O2 activation of protein kinase Cgamma.
Dingbo Lin, Samuel Lobell, Andrea Jewell et al. · PubMed · 2004 · 46 citations
Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer
Marwa Asem, Allison Young, Carlysa Oyama et al. · Scientific Reports · 2020 · 45 citations · Full text
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer
Vijayalaxmi Gupta, Jeff Hirst, Shariska Petersen et al. · Gynecologic Oncology · 2021 · 31 citations · Full text
Selective Hdac1/2 Inhibitor, Medicine, Pharmacology +7
A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.
Stéphanie Lheureux, Daniela Matei, Panagiotis A. Konstantinopoulos et al. · Journal of Clinical Oncology · 2020 · 29 citations
Medicine, Nivolumab Versus Nivolumab, Cancer Management +12
1–5 of 10